1 Study Coverage
    1.1 Therapeutic Peptide Product Introduction
    1.2 Market by Type
        1.2.1 Global Therapeutic Peptide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Oral
        1.2.3 Injection
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Therapeutic Peptide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Cancer
        1.3.3 Metabolic Disorders
        1.3.4 Central Nervous System
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Therapeutic Peptide Sales Estimates and Forecasts 2017-2028
    2.2 Global Therapeutic Peptide Revenue Estimates and Forecasts 2017-2028
    2.3 Global Therapeutic Peptide Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Therapeutic Peptide Sales by Region
        2.4.1 Global Therapeutic Peptide Sales by Region (2017-2022)
        2.4.2 Global Sales Therapeutic Peptide by Region (2023-2028)
    2.5 Global Therapeutic Peptide Revenue by Region
        2.5.1 Global Therapeutic Peptide Revenue by Region (2017-2022)
        2.5.2 Global Therapeutic Peptide Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Therapeutic Peptide Sales by Manufacturers
        3.1.1 Global Top Therapeutic Peptide Manufacturers by Sales (2017-2022)
        3.1.2 Global Therapeutic Peptide Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Therapeutic Peptide in 2021
    3.2 Global Therapeutic Peptide Revenue by Manufacturers
        3.2.1 Global Therapeutic Peptide Revenue by Manufacturers (2017-2022)
        3.2.2 Global Therapeutic Peptide Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Therapeutic Peptide Revenue in 2021
    3.3 Global Therapeutic Peptide Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Therapeutic Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Therapeutic Peptide Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Therapeutic Peptide Sales by Type
        4.1.1 Global Therapeutic Peptide Historical Sales by Type (2017-2022)
        4.1.2 Global Therapeutic Peptide Forecasted Sales by Type (2023-2028)
        4.1.3 Global Therapeutic Peptide Sales Market Share by Type (2017-2028)
    4.2 Global Therapeutic Peptide Revenue by Type
        4.2.1 Global Therapeutic Peptide Historical Revenue by Type (2017-2022)
        4.2.2 Global Therapeutic Peptide Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Therapeutic Peptide Revenue Market Share by Type (2017-2028)
    4.3 Global Therapeutic Peptide Price by Type
        4.3.1 Global Therapeutic Peptide Price by Type (2017-2022)
        4.3.2 Global Therapeutic Peptide Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Therapeutic Peptide Sales by Application
        5.1.1 Global Therapeutic Peptide Historical Sales by Application (2017-2022)
        5.1.2 Global Therapeutic Peptide Forecasted Sales by Application (2023-2028)
        5.1.3 Global Therapeutic Peptide Sales Market Share by Application (2017-2028)
    5.2 Global Therapeutic Peptide Revenue by Application
        5.2.1 Global Therapeutic Peptide Historical Revenue by Application (2017-2022)
        5.2.2 Global Therapeutic Peptide Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Therapeutic Peptide Revenue Market Share by Application (2017-2028)
    5.3 Global Therapeutic Peptide Price by Application
        5.3.1 Global Therapeutic Peptide Price by Application (2017-2022)
        5.3.2 Global Therapeutic Peptide Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Therapeutic Peptide Market Size by Type
        6.1.1 North America Therapeutic Peptide Sales by Type (2017-2028)
        6.1.2 North America Therapeutic Peptide Revenue by Type (2017-2028)
    6.2 North America Therapeutic Peptide Market Size by Application
        6.2.1 North America Therapeutic Peptide Sales by Application (2017-2028)
        6.2.2 North America Therapeutic Peptide Revenue by Application (2017-2028)
    6.3 North America Therapeutic Peptide Market Size by Country
        6.3.1 North America Therapeutic Peptide Sales by Country (2017-2028)
        6.3.2 North America Therapeutic Peptide Revenue by Country (2017-2028)
        6.3.3 United States
        6.3.4 Canada
7 Europe
    7.1 Europe Therapeutic Peptide Market Size by Type
        7.1.1 Europe Therapeutic Peptide Sales by Type (2017-2028)
        7.1.2 Europe Therapeutic Peptide Revenue by Type (2017-2028)
    7.2 Europe Therapeutic Peptide Market Size by Application
        7.2.1 Europe Therapeutic Peptide Sales by Application (2017-2028)
        7.2.2 Europe Therapeutic Peptide Revenue by Application (2017-2028)
    7.3 Europe Therapeutic Peptide Market Size by Country
        7.3.1 Europe Therapeutic Peptide Sales by Country (2017-2028)
        7.3.2 Europe Therapeutic Peptide Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Therapeutic Peptide Market Size by Type
        8.1.1 Asia Pacific Therapeutic Peptide Sales by Type (2017-2028)
        8.1.2 Asia Pacific Therapeutic Peptide Revenue by Type (2017-2028)
    8.2 Asia Pacific Therapeutic Peptide Market Size by Application
        8.2.1 Asia Pacific Therapeutic Peptide Sales by Application (2017-2028)
        8.2.2 Asia Pacific Therapeutic Peptide Revenue by Application (2017-2028)
    8.3 Asia Pacific Therapeutic Peptide Market Size by Region
        8.3.1 Asia Pacific Therapeutic Peptide Sales by Region (2017-2028)
        8.3.2 Asia Pacific Therapeutic Peptide Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Therapeutic Peptide Market Size by Type
        9.1.1 Latin America Therapeutic Peptide Sales by Type (2017-2028)
        9.1.2 Latin America Therapeutic Peptide Revenue by Type (2017-2028)
    9.2 Latin America Therapeutic Peptide Market Size by Application
        9.2.1 Latin America Therapeutic Peptide Sales by Application (2017-2028)
        9.2.2 Latin America Therapeutic Peptide Revenue by Application (2017-2028)
    9.3 Latin America Therapeutic Peptide Market Size by Country
        9.3.1 Latin America Therapeutic Peptide Sales by Country (2017-2028)
        9.3.2 Latin America Therapeutic Peptide Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Therapeutic Peptide Market Size by Type
        10.1.1 Middle East and Africa Therapeutic Peptide Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Therapeutic Peptide Revenue by Type (2017-2028)
    10.2 Middle East and Africa Therapeutic Peptide Market Size by Application
        10.2.1 Middle East and Africa Therapeutic Peptide Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Therapeutic Peptide Revenue by Application (2017-2028)
    10.3 Middle East and Africa Therapeutic Peptide Market Size by Country
        10.3.1 Middle East and Africa Therapeutic Peptide Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Therapeutic Peptide Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 AbbVie
        11.1.1 AbbVie Corporation Information
        11.1.2 AbbVie Overview
        11.1.3 AbbVie Therapeutic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 AbbVie Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 AbbVie Recent Developments
    11.2 AstraZeneca
        11.2.1 AstraZeneca Corporation Information
        11.2.2 AstraZeneca Overview
        11.2.3 AstraZeneca Therapeutic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 AstraZeneca Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 AstraZeneca Recent Developments
    11.3 Ipsen
        11.3.1 Ipsen Corporation Information
        11.3.2 Ipsen Overview
        11.3.3 Ipsen Therapeutic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Ipsen Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Ipsen Recent Developments
    11.4 Eli Lilly
        11.4.1 Eli Lilly Corporation Information
        11.4.2 Eli Lilly Overview
        11.4.3 Eli Lilly Therapeutic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Eli Lilly Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Eli Lilly Recent Developments
    11.5 Merck
        11.5.1 Merck Corporation Information
        11.5.2 Merck Overview
        11.5.3 Merck Therapeutic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Merck Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Merck Recent Developments
    11.6 Novo Nordisk
        11.6.1 Novo Nordisk Corporation Information
        11.6.2 Novo Nordisk Overview
        11.6.3 Novo Nordisk Therapeutic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Novo Nordisk Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Novo Nordisk Recent Developments
    11.7 Novartis
        11.7.1 Novartis Corporation Information
        11.7.2 Novartis Overview
        11.7.3 Novartis Therapeutic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Novartis Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Novartis Recent Developments
    11.8 Johnson and Johnson
        11.8.1 Johnson and Johnson Corporation Information
        11.8.2 Johnson and Johnson Overview
        11.8.3 Johnson and Johnson Therapeutic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Johnson and Johnson Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Johnson and Johnson Recent Developments
    11.9 Sanofi
        11.9.1 Sanofi Corporation Information
        11.9.2 Sanofi Overview
        11.9.3 Sanofi Therapeutic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Sanofi Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Sanofi Recent Developments
    11.10 Teva
        11.10.1 Teva Corporation Information
        11.10.2 Teva Overview
        11.10.3 Teva Therapeutic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Teva Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Teva Recent Developments
    11.11 Takeda
        11.11.1 Takeda Corporation Information
        11.11.2 Takeda Overview
        11.11.3 Takeda Therapeutic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Takeda Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Takeda Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Therapeutic Peptide Industry Chain Analysis
    12.2 Therapeutic Peptide Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Therapeutic Peptide Production Mode & Process
    12.4 Therapeutic Peptide Sales and Marketing
        12.4.1 Therapeutic Peptide Sales Channels
        12.4.2 Therapeutic Peptide Distributors
    12.5 Therapeutic Peptide Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Therapeutic Peptide Industry Trends
    13.2 Therapeutic Peptide Market Drivers
    13.3 Therapeutic Peptide Market Challenges
    13.4 Therapeutic Peptide Market Restraints
14 Key Findings in The Global Therapeutic Peptide Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Therapeutic Peptide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Oral
    Table 3. Major Manufacturers of Injection
    Table 4. Major Manufacturers of Other
    Table 5. Global Therapeutic Peptide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Therapeutic Peptide Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Therapeutic Peptide Sales by Region (2017-2022) & (K Units)
    Table 8. Global Therapeutic Peptide Sales Market Share by Region (2017-2022)
    Table 9. Global Therapeutic Peptide Sales by Region (2023-2028) & (K Units)
    Table 10. Global Therapeutic Peptide Sales Market Share by Region (2023-2028)
    Table 11. Global Therapeutic Peptide Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Therapeutic Peptide Revenue Market Share by Region (2017-2022)
    Table 13. Global Therapeutic Peptide Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Therapeutic Peptide Revenue Market Share by Region (2023-2028)
    Table 15. Global Therapeutic Peptide Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Therapeutic Peptide Sales Share by Manufacturers (2017-2022)
    Table 17. Global Therapeutic Peptide Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Therapeutic Peptide Revenue Share by Manufacturers (2017-2022)
    Table 19. Therapeutic Peptide Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 20. Global Therapeutic Peptide Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Therapeutic Peptide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Peptide as of 2021)
    Table 22. Therapeutic Peptide Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Therapeutic Peptide Product Offered
    Table 24. Date of Manufacturers Enter into Therapeutic Peptide Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Therapeutic Peptide Sales by Type (2017-2022) & (K Units)
    Table 27. Global Therapeutic Peptide Sales by Type (2023-2028) & (K Units)
    Table 28. Global Therapeutic Peptide Sales Share by Type (2017-2022)
    Table 29. Global Therapeutic Peptide Sales Share by Type (2023-2028)
    Table 30. Global Therapeutic Peptide Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Therapeutic Peptide Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Therapeutic Peptide Revenue Share by Type (2017-2022)
    Table 33. Global Therapeutic Peptide Revenue Share by Type (2023-2028)
    Table 34. Therapeutic Peptide Price by Type (2017-2022) & (US$/Unit)
    Table 35. Global Therapeutic Peptide Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 36. Global Therapeutic Peptide Sales by Application (2017-2022) & (K Units)
    Table 37. Global Therapeutic Peptide Sales by Application (2023-2028) & (K Units)
    Table 38. Global Therapeutic Peptide Sales Share by Application (2017-2022)
    Table 39. Global Therapeutic Peptide Sales Share by Application (2023-2028)
    Table 40. Global Therapeutic Peptide Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Therapeutic Peptide Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Therapeutic Peptide Revenue Share by Application (2017-2022)
    Table 43. Global Therapeutic Peptide Revenue Share by Application (2023-2028)
    Table 44. Therapeutic Peptide Price by Application (2017-2022) & (US$/Unit)
    Table 45. Global Therapeutic Peptide Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 46. North America Therapeutic Peptide Sales by Type (2017-2022) & (K Units)
    Table 47. North America Therapeutic Peptide Sales by Type (2023-2028) & (K Units)
    Table 48. North America Therapeutic Peptide Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Therapeutic Peptide Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Therapeutic Peptide Sales by Application (2017-2022) & (K Units)
    Table 51. North America Therapeutic Peptide Sales by Application (2023-2028) & (K Units)
    Table 52. North America Therapeutic Peptide Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Therapeutic Peptide Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Therapeutic Peptide Sales by Country (2017-2022) & (K Units)
    Table 55. North America Therapeutic Peptide Sales by Country (2023-2028) & (K Units)
    Table 56. North America Therapeutic Peptide Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Therapeutic Peptide Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Therapeutic Peptide Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Therapeutic Peptide Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Therapeutic Peptide Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Therapeutic Peptide Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Therapeutic Peptide Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Therapeutic Peptide Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Therapeutic Peptide Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Therapeutic Peptide Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Therapeutic Peptide Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Therapeutic Peptide Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Therapeutic Peptide Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Therapeutic Peptide Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Therapeutic Peptide Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Therapeutic Peptide Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Therapeutic Peptide Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Therapeutic Peptide Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Therapeutic Peptide Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Therapeutic Peptide Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Therapeutic Peptide Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Therapeutic Peptide Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Therapeutic Peptide Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Therapeutic Peptide Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Therapeutic Peptide Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Therapeutic Peptide Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Therapeutic Peptide Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Therapeutic Peptide Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Therapeutic Peptide Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Therapeutic Peptide Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Therapeutic Peptide Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Therapeutic Peptide Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Therapeutic Peptide Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Therapeutic Peptide Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Therapeutic Peptide Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Therapeutic Peptide Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Therapeutic Peptide Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Therapeutic Peptide Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Therapeutic Peptide Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Therapeutic Peptide Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Therapeutic Peptide Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Therapeutic Peptide Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Therapeutic Peptide Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Therapeutic Peptide Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Therapeutic Peptide Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Therapeutic Peptide Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Therapeutic Peptide Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Therapeutic Peptide Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Therapeutic Peptide Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Therapeutic Peptide Revenue by Country (2023-2028) & (US$ Million)
    Table 106. AbbVie Corporation Information
    Table 107. AbbVie Description and Major Businesses
    Table 108. AbbVie Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 109. AbbVie Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. AbbVie Recent Developments
    Table 111. AstraZeneca Corporation Information
    Table 112. AstraZeneca Description and Major Businesses
    Table 113. AstraZeneca Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 114. AstraZeneca Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. AstraZeneca Recent Developments
    Table 116. Ipsen Corporation Information
    Table 117. Ipsen Description and Major Businesses
    Table 118. Ipsen Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 119. Ipsen Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Ipsen Recent Developments
    Table 121. Eli Lilly Corporation Information
    Table 122. Eli Lilly Description and Major Businesses
    Table 123. Eli Lilly Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 124. Eli Lilly Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Eli Lilly Recent Developments
    Table 126. Merck Corporation Information
    Table 127. Merck Description and Major Businesses
    Table 128. Merck Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 129. Merck Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Merck Recent Developments
    Table 131. Novo Nordisk Corporation Information
    Table 132. Novo Nordisk Description and Major Businesses
    Table 133. Novo Nordisk Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 134. Novo Nordisk Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Novo Nordisk Recent Developments
    Table 136. Novartis Corporation Information
    Table 137. Novartis Description and Major Businesses
    Table 138. Novartis Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 139. Novartis Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Novartis Recent Developments
    Table 141. Johnson and Johnson Corporation Information
    Table 142. Johnson and Johnson Description and Major Businesses
    Table 143. Johnson and Johnson Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 144. Johnson and Johnson Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Johnson and Johnson Recent Developments
    Table 146. Sanofi Corporation Information
    Table 147. Sanofi Description and Major Businesses
    Table 148. Sanofi Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 149. Sanofi Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Sanofi Recent Developments
    Table 151. Teva Corporation Information
    Table 152. Teva Description and Major Businesses
    Table 153. Teva Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 154. Teva Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Teva Recent Developments
    Table 156. Takeda Corporation Information
    Table 157. Takeda Description and Major Businesses
    Table 158. Takeda Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 159. Takeda Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. Takeda Recent Developments
    Table 161. Key Raw Materials Lists
    Table 162. Raw Materials Key Suppliers Lists
    Table 163. Therapeutic Peptide Distributors List
    Table 164. Therapeutic Peptide Customers List
    Table 165. Therapeutic Peptide Market Trends
    Table 166. Therapeutic Peptide Market Drivers
    Table 167. Therapeutic Peptide Market Challenges
    Table 168. Therapeutic Peptide Market Restraints
    Table 169. Research Programs/Design for This Report
    Table 170. Key Data Information from Secondary Sources
    Table 171. Key Data Information from Primary Sources
List of Figures
    Figure 1. Therapeutic Peptide Product Picture
    Figure 3. Global Therapeutic Peptide Market Share by Type in 2021 & 2028
    Figure 3. Oral Product Picture
    Figure 4. Injection Product Picture
    Figure 5. Other Product Picture
    Figure 6. Global Therapeutic Peptide Market Share by Application in 2021 & 2028
    Figure 7. Cancer
    Figure 8. Metabolic Disorders
    Figure 9. Central Nervous System
    Figure 10. Other
    Figure 11. Therapeutic Peptide Report Years Considered
    Figure 12. Global Therapeutic Peptide Sales 2017-2028 (K Units)
    Figure 13. Global Therapeutic Peptide Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Therapeutic Peptide Revenue 2017-2028 (US$ Million)
    Figure 15. Global Therapeutic Peptide Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Therapeutic Peptide Sales Market Share by Region (2017-2022)
    Figure 17. Global Therapeutic Peptide Sales Market Share by Region (2023-2028)
    Figure 18. North America Therapeutic Peptide Sales YoY (2017-2028) & (K Units)
    Figure 19. North America Therapeutic Peptide Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Therapeutic Peptide Sales YoY (2017-2028) & (K Units)
    Figure 21. Europe Therapeutic Peptide Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Therapeutic Peptide Sales YoY (2017-2028) & (K Units)
    Figure 23. Asia-Pacific Therapeutic Peptide Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Therapeutic Peptide Sales YoY (2017-2028) & (K Units)
    Figure 25. Latin America Therapeutic Peptide Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Therapeutic Peptide Sales YoY (2017-2028) & (K Units)
    Figure 27. Middle East & Africa Therapeutic Peptide Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Therapeutic Peptide Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Therapeutic Peptide in the World: Market Share by Therapeutic Peptide Revenue in 2021
    Figure 30. Global Therapeutic Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Therapeutic Peptide Sales Market Share by Type (2017-2028)
    Figure 32. Global Therapeutic Peptide Revenue Market Share by Type (2017-2028)
    Figure 33. Global Therapeutic Peptide Sales Market Share by Application (2017-2028)
    Figure 34. Global Therapeutic Peptide Revenue Market Share by Application (2017-2028)
    Figure 35. North America Therapeutic Peptide Sales Market Share by Type (2017-2028)
    Figure 36. North America Therapeutic Peptide Revenue Market Share by Type (2017-2028)
    Figure 37. North America Therapeutic Peptide Sales Market Share by Application (2017-2028)
    Figure 38. North America Therapeutic Peptide Revenue Market Share by Application (2017-2028)
    Figure 39. North America Therapeutic Peptide Sales Share by Country (2017-2028)
    Figure 40. North America Therapeutic Peptide Revenue Share by Country (2017-2028)
    Figure 41. United States Therapeutic Peptide Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Therapeutic Peptide Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Therapeutic Peptide Sales Market Share by Type (2017-2028)
    Figure 44. Europe Therapeutic Peptide Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Therapeutic Peptide Sales Market Share by Application (2017-2028)
    Figure 46. Europe Therapeutic Peptide Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Therapeutic Peptide Sales Share by Country (2017-2028)
    Figure 48. Europe Therapeutic Peptide Revenue Share by Country (2017-2028)
    Figure 49. Germany Therapeutic Peptide Revenue (2017-2028) & (US$ Million)
    Figure 50. France Therapeutic Peptide Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Therapeutic Peptide Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Therapeutic Peptide Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Therapeutic Peptide Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Therapeutic Peptide Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Therapeutic Peptide Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Therapeutic Peptide Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Therapeutic Peptide Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Therapeutic Peptide Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Therapeutic Peptide Revenue Share by Region (2017-2028)
    Figure 60. China Therapeutic Peptide Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Therapeutic Peptide Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Therapeutic Peptide Revenue (2017-2028) & (US$ Million)
    Figure 63. India Therapeutic Peptide Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Therapeutic Peptide Revenue (2017-2028) & (US$ Million)
    Figure 65. China Taiwan Therapeutic Peptide Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Therapeutic Peptide Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Therapeutic Peptide Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Therapeutic Peptide Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Therapeutic Peptide Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Therapeutic Peptide Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Therapeutic Peptide Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Therapeutic Peptide Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Therapeutic Peptide Sales Share by Country (2017-2028)
    Figure 74. Latin America Therapeutic Peptide Revenue Share by Country (2017-2028)
    Figure 75. Mexico Therapeutic Peptide Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Therapeutic Peptide Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Therapeutic Peptide Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Therapeutic Peptide Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Therapeutic Peptide Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Therapeutic Peptide Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Therapeutic Peptide Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Therapeutic Peptide Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Therapeutic Peptide Revenue Share by Country (2017-2028)
    Figure 84. Turkey Therapeutic Peptide Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Therapeutic Peptide Revenue (2017-2028) & (US$ Million)
    Figure 86. UAE Therapeutic Peptide Revenue (2017-2028) & (US$ Million)
    Figure 87. Therapeutic Peptide Value Chain
    Figure 88. Therapeutic Peptide Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed